Anita Treohan brings extensive and diverse drug development expertise coupled with experience in building sustainable and high-functioning teams at several life sciences companies. At AVROBIO, she steers a multi-disciplinary operational team to foster a culture of execution, compliance and quality.

Previously, she served as Vice President, Development Operations at IMARA, spearheading the strategic and operational execution of two rare disease programs and maximizing organizational efficiency across clinical development. As the Portfolio and Program Manager and Interim Regulatory and QA Lead at Axcella Health, she led strategic, portfolio and product development for all assets while building a sustainable infrastructure across all drug development functions. In prior program and operational roles at ImmusanT, FORUM Pharmaceuticals, Pfizer and GlaxoSmithKline, she advanced portfolio and development strategies for Phase 1 – 4 global clinical programs and studies across multiple therapeutic areas, including rare, pediatric and vulnerable populations.

Anita maintains certifications in Project Management and Lean Six Sigma. In 2018, she served on the advisory committee for the Clinical Leader Forum and was accepted to Harvard University’s Women on Boards program. She earned her B.S. in Biology from Emory University and her MPH in Epidemiology, Biostatistics and Social Behavioral Sciences from Boston University.